Our guest is Dr. Daniel Parker, an associate professor at the University of Oklahoma Health Sciences Center, who specializes in urologic oncology. He is here to talk with us about Hormone Sensitive Prostate Cancer and treatment intensification.
Short on time? Use the below timestamps to jump to any topic section:
0:38 - Introduction
1:02 - What is Hormone Sensitive Prostate Cancer (HSPC)?
2:25 - How common is HSPC?
4:01 - Types of treatment intensification for HSPC
7:16 - What can patients and caregivers expect after treatment for HSPC?
10:46 - Questions for patients and caregivers to ask their doctor
15:35 - Advice for patients and caregivers about treatment for HSPC
17:56 - Final thoughts
Supported by an independent educational grant from Astellas and Pfizer, Inc.
For more information, please subscribe to our free digital magazine, UrologyHealth extra.
****
July 6, 2023
Explore Further
Share Your Story
Have a story to share? The Urology Care Foundation invites you to share your experience with a urologic condition and how it has affected you or your family.
Make a Differnece
Your tax-deductible gift will help support the millions of patients who are faced with urologic disease. Together, we care.